Neuropsychological profile of amyloid-positive versus amyloid-negative amnestic Mild Cognitive Impairment

• Autor(a) principal: Alves, Luísa
• Data de Publicação: 2020
• Outros Autores: Cardoso, Sandra, Silva, Dina, Mendes, Tiago, Maroco, J. P., Nogueira, Joana, Lima, Marisa, Pereira, Miguel Tábuas, Baldeiras, Inês, Santana, Isabel, De Mendonça, Alexandre, Guerreiro, Manuela
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10400.12/7688

Patients diagnosed with amnestic mild cognitive impairment (aMCI) are at high risk of progressing to dementia. It became possible, through the use of biomarkers, to diagnose those patients with aMCI who have Alzheimer's disease. However, it is presently unfeasible that all patients undergo biomarker testing. Since neuropsychological testing is required to make a formal diagnosis of aMCI, it would be interesting if it could be used to predict the amyloid status of patients with aMCI.